Largest profit: Novo Nordisk Pharmatech A/S (2017) '103,665 DKK
Most equity: Novo Nordisk Pharmatech A/S (2017) '528,953 DKK
Biggest loss: EYE-GO A/S (2017) '12,631 DKK
Active
Director (2017-11-10 - present)
Board member (2017-11-10 - present)
Active
Board member (2022-05-18 - 2024-05-27)
Active
Board member (2005-04-12 - 2007-12-17)
Active
Board member (2023-06-14 - 2025-03-28)
Active
Board member (2022-05-18 - 2024-05-27)
Active
Board member (2004-01-23 - 2007-05-23)
Active
Board member (2020-06-19 - 2024-05-27)
Active
Director (2017-11-10 - present)
Board member (2017-11-10 - present)